Showing results (91-100 of 155) with videos related to

Sort By:
Pageof 16
World Journal of Gastroenterology|December 12, 2003
Spider angiomas in patients with liver cirrhosis: role of vascular endothelial growth factor and basic fibroblast growth factorChung-Pin Li, Fa-Yauh Lee, Shinn-Jang Hwang, et al.
Journal of the Chinese Medical Association : JCMA|February 8, 2017
Evaluation of prognostic factors and implication of lymph node dissection in intrahepatic cholangiocarcinoma: 10-year experience at a tertiary referral centerMiao-Erh Chang, Hao-Jan Lei, Ming-Huang Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|June 12, 2014
A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreasJeffrey R Infante, Bradley G Somer, Joon Oh Park, et al.
Pancreas|December 20, 2019
Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 TrialTeresa Macarulla Mercadé, Li-Tzong Chen, Chung-Pin Li, et al.
Hepato-Gastroenterology|September 21, 2002
Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromesJiing-Chyuan Luo, Shinn-Jang Hwang, Jaw-Ching Wu, et al.
Molecular Nutrition & Food Research|December 1, 2020
Active Vitamin D<sub>3</sub> Treatment Attenuated Bacterial Translocation via Improving Intestinal Barriers in Cirrhotic RatsPei-Chang Lee, Yun-Chen Hsieh, Teh-Ia Huo, et al.
Pancreas|March 6, 2020
Landscape of Health-Related Quality of Life in Patients With Early-Stage Pancreatic Cancer Receiving Adjuvant or Neoadjuvant Chemotherapy: A Systematic Literature ReviewTeresa Macarulla, Andrew E Hendifar, Chung-Pin Li, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2023
Carbohydrate Antigen 19-9 Response to Initial Adjuvant Chemotherapy Predicts Survival and Failure Pattern of Resected Pancreatic Adenocarcinoma but Not Which Patients Are Suited for Additional Adjuvant Chemoradiation Therapy: From a Prospective Randomized StudyYen-Feng Chiu, Tsang-Wu Liu, Yan-Shen Shan, et al.
Cancer Medicine|October 16, 2023
Efficacy and safety of abemaciclib alone and with PI3K/mTOR inhibitor LY3023414 or galunisertib versus chemotherapy in previously treated metastatic pancreatic adenocarcinoma: A randomized controlled trialE Gabriela Chiorean, Vincent Picozzi, Chung-Pin Li, et al.
Oncology|July 12, 2014
Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancerYing-Chun Shen, Chung-Pin Li, Chia-Jui Yen, et al.
Pageof 16